Eckert & Ziegler Strahlen- und Medizintechnik AG (0NZY.L)

39,73 +1,73 (+4,56%) Al 05:17PM GMT. Mercato aperto.

Eckert & Ziegler Strahlen- und Medizintechnik AG

Robert-Rössle-Strasse 10
Berlin 13125
Germany
49 30 94 10 84 0
https://www.ezag.com

Settore/i: 
Settore: 
Impiegati a tempo pieno: 945

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Dr. Andreas Eckert Ph.D.	Chairman of Exec. Board & CEO	340,75k	N/D	1960
Dr. Harald Hasselmann	Head of Radiation Therapy Segment & Member of the Exec. Board - Medical Segment	258,56k	N/D	1967
Dr. Lutz Helmke	Member of Exec. Board - Medical Segment	254,19k	N/D	1961
Ms. Jutta Ludwig	Member of Exec. Board - Asia Bus.	21k	N/D	1953
Dr. Hakim Bouterfa	Member of the Exec. Board & Head of Clinical Devel.	N/D	N/D	1962
Dr. Gunnar Mann	Head of Intragroup Services	N/D	N/D	1967
Mr. Franklin B. Yeager	Pres of Eckert & Ziegler Isotope Products Inc.	N/D	N/D	N/D
Mr. Joseph Hathcock	VP of Eckert & Ziegler Isotope Products Inc	N/D	N/D	N/D
Ivan Simmer	Managing Director of Eckert & Ziegler Cesio s.r.o.	N/D	N/D	N/D
Ms. Claudia Goulart	MD - Eckert & Ziegler Brasil Participacoes, Comericial & Logistica Ltda.	N/D	N/D	N/D

Gli importi risalgono al giorno 31 dicembre 2021 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in EUR.

Descrizione

Eckert & Ziegler Strahlen- und Medizintechnik AG, through its subsidiaries, manufactures and sells isotope technology components for medical, scientific, and industrial applications worldwide. It operates in two segments, Medical and Isotope Products. The Medical segment offers small radioactive implants for the treatment of prostate cancer seeds; and eye application based on ruthenium-106 or iodine-125 for treating uveal melanoma. This segment also provides radiopharmaceuticals, laboratory equipment, hot cells, and services for radiopharmaceuticals, as well as eye applicators and prostate implants. The Isotope Products segment manufactures and sells radiation sources for imaging, measurement technology, material analysis, quality assurance, and environmental monitoring. This segment also offers calibration sources for medical imaging systems, and homeland security and radiometric level measurement products. The company was founded in 1992 and is headquartered in Berlin, Germany.

Governance aziendale

L'ISS Governance QualityScore di Eckert & Ziegler Strahlen- und Medizintechnik AG al 28 gennaio 2023 è 9. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 9; diritti degli azionisti: 1; retribuzione: 9.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.